...that first quarter sales of osteoporosis drug Forteoteriparatide fell 10% year-over-year to $313.2 million. Forteo... ...the 2018 formulary for Express Scripts Holding Co. (NASDAQ:ESRX) just months after its launch, knocking Forteo... ...onto the excluded list (see BioCentury, Aug. 11, 2017) . Consensus figures provided by FactSet.
Mary Romeo
abaloparatide-SC
Basaglar
dulaglutide
empagliflozin
Forteo
insulin...